Development and Validation of a Prediction Rule for Estimating Gastric Cancer Risk in the Chinese High-Risk Population: a Nationwide Multicentre Study
Quancai Cai,Chunping Zhu,Yuan,Qi Feng,Yichao Feng,Yingxia Hao,Jichang Li,Kaiguang Zhang,Guoliang Ye,Liping Ye,Nonghua Lv,Shengsheng Zhang,Chengxia Liu,Mingquan Li,Qi Liu,Rongzhou Li,Jie Pan,Xiaocui Yang,Xuqing Zhu,Yumei Li,Bo Lao,Ansheng Ling,Honghui Chen,Xiuling Li,Ping Xu,Jianfeng Zhou,Baozhen Liu,Zhiqiang Du,Yiqi Du,Zhaoshen Li
DOI: https://doi.org/10.1136/gutjnl-2018-317556
IF: 24.5
2019-01-01
Gut
Abstract:ObjectiveTo develop a gastric cancer (GC) risk prediction rule as an initial prescreening tool to identify individuals with a high risk prior to gastroscopy.DesignThis was a nationwide multicentre cross-sectional study. Individuals aged 40–80 years who went to hospitals for a GC screening gastroscopy were recruited. Serum pepsinogen (PG) I, PG II, gastrin-17 (G-17) and anti-Helicobacter pylori IgG antibody concentrations were tested prior to endoscopy. Eligible participants (n=14 929) were randomly assigned into the derivation and validation cohorts, with a ratio of 2:1. Risk factors for GC were identified by univariate and multivariate analyses and an optimal prediction rule was then settled.ResultsThe novel GC risk prediction rule comprised seven variables (age, sex, PG I/II ratio, G-17 level, H. pylori infection, pickled food and fried food), with scores ranging from 0 to 25. The observed prevalence rates of GC in the derivation cohort at low-risk (≤11), medium-risk (12–16) or high-risk (17–25) group were 1.2%, 4.4% and 12.3%, respectively (p<0.001).When gastroscopy was used for individuals with medium risk and high risk, 70.8% of total GC cases and 70.3% of early GC cases were detected. While endoscopy requirements could be reduced by 66.7% according to the low-risk proportion. The prediction rule owns a good discrimination, with an area under curve of 0.76, or calibration (p<0.001).ConclusionsThe developed and validated prediction rule showed good performance on identifying individuals at a higher risk in a Chinese high-risk population. Future studies are needed to validate its efficacy in a larger population.